Karessa Pharma Holding AB (publ) Share Price

Karessa Pharma Holding AB (publ) is a Sweden-based pharmaceutical company with the goal of developing products based on a patented drug delivery platform with direct absorption of active substances from the oral cavity to the bloodstream. The drug delivery platform is in the form of buccal film, an alignate-based polymer film, which is applied to the oral mucosa and through it the drug is then rapidly delivered into the bloodstream, while the film dissolves without leaving any residues in the mouth. The Company's research and development projects are based on active substances that have already been approved for use as medicinal products in other forms, and include, among others, Karessa k03 vardenafil via buccal film for the treatment of erectile dysfunction and Karessa k21 midazolam via buccal film for the treatment of anxiety and epilepsy symptoms.